Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2014
11/20/2014US20140343284 Malonic acid di-salts and a method for preparing malonyl dihalides
11/20/2014US20140343277 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
11/20/2014US20140343092 Pyrrolopyridinone Compounds And Methods For Treating HIV
11/20/2014US20140343078 Compositions and methods for inhibiting cytochrome p450 2d6
11/20/2014US20140343077 Hepatitis c inhibitor compounds
11/20/2014US20140343066 5-substituted indazoles as kinase inhibitors
11/20/2014US20140343065 New Somatostatin receptor subtype 4 (SSTR4) agonists
11/20/2014US20140343056 Azaindazoles
11/20/2014US20140343055 Kinase inhibitors
11/20/2014US20140343054 Therapeutic Use of Imidazopyridine Derivatives
11/20/2014US20140343053 Triazolopyridinone pde10 inhibitors
11/20/2014US20140343038 1,2,4-triazine-6-carboxamide derivative
11/20/2014US20140343036 Isoquinoline and naphthyridine derivatives
11/20/2014US20140343033 Azaindole derivatives
11/20/2014US20140343018 Anti-depression Compounds
11/18/2014US8889870 Kinase inhibitors
11/18/2014US8889869 Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound
11/18/2014US8889868 CC-1065 analogs and their conjugates
11/18/2014US8889867 Solid forms and process for preparing
11/18/2014US8889711 Pyrazolopyridine derivatives as anticancer agent
11/18/2014US8889706 Soluble mTOR complexes and modulators thereof
11/18/2014US8889704 Triazolopyridine compounds as PIM kinase inhibitors
11/18/2014US8889703 Inhibitors of beta-secretase
11/18/2014US8889696 Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof
11/18/2014US8889687 Deuterated pyrazinoisoquinoline compounds
11/18/2014US8889686 Method of decreasing the bitterness of a pharmaceutical dosage form containing zopiclone
11/18/2014US8889685 Method for treating a sleep disorder with eszopiclone maleate
11/18/2014US8889684 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
11/18/2014US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies
11/18/2014US8889675 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/18/2014US8889674 Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
11/18/2014US8889673 Triazolopyridine JAK inhibitor compounds and methods
11/18/2014US8889666 Quinolyl pyrrolo pyrimidyl condensed-ring compound and salt thereof
11/18/2014US8889420 Photoconductive sensor materials for detection of explosive vapor
11/18/2014US8889270 Organic light-emitting device
11/18/2014US8889267 Organic light emitting device
11/13/2014US20140336377 Arylamide derivatives as ttx-s blockers
11/13/2014US20140336374 Process and intermediates for the production of ccr2 antagonists
11/13/2014US20140336200 Arylosulfonamides for the treatment of cns diseases
11/13/2014US20140336195 Aryloxmethyl cyclopropane derivatives as pde10 inhibitors
11/13/2014US20140336190 Benzimidazole derivatives as bromodomain inhibitors
11/13/2014US20140336182 Aurora Kinase Modulators and Method of Use
11/13/2014US20140336176 Heteroaromatic compounds and their use as dopamine d1 ligands
11/13/2014US20140336171 Azaindoles useful as inhibitors of janus kinases
11/13/2014US20140336169 Imidazopyrazine syk inhibitors
11/13/2014US20140336158 Nk1 antagonists
11/13/2014US20140336153 Substituted pyridine derivatives as fabi inhibitors
11/13/2014US20140335048 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, Salts Thereof and Methods of Using the Same in Combination Therapy
11/13/2014US20140335019 Compositions and methods for the treatment and analysis of neurological disorders
11/11/2014US8884016 Apixaban preparation process
11/11/2014US8883828 2-aminopyridine analogs as glucokinase activators
11/11/2014US8883826 Alkynyl derivatives as modulators of metabotropic glutamate receptors
11/11/2014US8883821 Substituted pyrazolo[3,4-b]pyridines as medicaments
11/11/2014US8883820 Triazole derivatives as kinase inhibitors
11/11/2014US8883819 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
11/11/2014US8883818 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
11/11/2014US8883810 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
11/11/2014US8883807 Piperidinone carboxamide indane CGRP receptor antagonists
11/11/2014US8883802 Co-crystals of a triazolo [4,5-D] pyrimide platelet aggregation inhibitor
11/11/2014US8883799 Tricyclic PI3K inhibitor compounds and methods of use
11/11/2014US8883790 Pharmaceutical combinations
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
11/11/2014US8883788 Fused heterocyclic ring compound
11/11/2014US8883786 Glucocorticoid receptor antagonists
11/11/2014US8883784 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/06/2014US20140330009 Substituted 4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridines, Their Use as Medicament, and Pharmaceutical Preparations Comprising Them
11/06/2014US20140329986 New Amide-Imide Compounds and Their Corresponding Polymers
11/06/2014US20140329853 [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors
11/06/2014US20140329852 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
11/06/2014US20140329850 Apoptosis signal-regulating kinase 1 inhibitors
11/06/2014US20140329839 New Crystalline Form of Pemirolast
11/06/2014US20140329820 Triazine Derivatives
11/06/2014US20140329807 Heterocyclic protein kinase inhibitors
11/06/2014US20140329805 Dual small molecule inhibitors of cancer and angiogenesis
11/06/2014US20140329804 Novel phosphodiesterase inhibitors and uses thereof
11/06/2014US20140329798 Substituted cyclopropyl compounds useful as gpr119 agonists
11/06/2014US20140329795 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140328805 Biheteroaryl compounds and uses thereof
11/04/2014US8877934 N-heteroaryl compounds
11/04/2014US8877921 Synthetic voacangine
11/04/2014US8877815 Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
11/04/2014US8877797 Methods for treating Parkinson's disease using pro-neurogenic compounds
11/04/2014US8877779 Benzimidazole compound and pharmaceutical use thereof
11/04/2014US8877772 Substituted pyrrolo[2,3-B]pyridines as MLK inhibitors
11/04/2014US8877765 Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer
11/04/2014US8877763 Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors
11/04/2014US8877757 Pyrazine derivatives and use as PI3K inhibitors
11/04/2014US8877753 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
11/04/2014US8877749 Spirocyclic compounds as modulators of chemokine receptor activity
11/04/2014US8877745 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/04/2014US8877743 Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
11/04/2014US8877742 Compounds
11/04/2014US8877707 Inhibitors of HCV NS5A
11/04/2014US8877354 Heterocyclic compound and organic light-emitting device using the same
10/2014
10/30/2014US20140323730 Substituted acetyl-coa carboxylase inhibitors
10/30/2014US20140323721 Heterocyclic compounds and uses thereof
10/30/2014US20140323504 Pyrazolo[4,3-c]Pyridine Derivatives As Kinase Inhibitors
10/30/2014US20140323500 Nadph oxidase 4 inhibitors and use thereof
10/30/2014US20140323491 Substituted heterocycle fused gamma-carbolines solid
10/30/2014US20140323481 3-cyanoaryl-1h-pyrrolo[2,3-b]pyridine derivatives
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 646